1. Lambert, H.; Gupte, J.; Fletcher, H.; Hammond, L.; Lowe, N.; Pelling, M.; Raina, N.; Shahid, T.; Shanks, K. COVID-19 as a global challenge: towards an inclusive and sustainable future. Lancet Planet Health. 2020, 4, e312-e314.

2. Tiboni, M.; Casettari, L.; Illum, L. Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines? Int J Pharm. 2021, 603, 120686.

3. Hassan, A. O.; Kafai, N. M.; Dmitriev, I. P.; Fox, J. M.; Smith, B. K.; Harvey, I. B.; Chen, R. E.; Winkler, E. S.; Wessel, A. W.; Case, J. B.; Kashentseva, E.; McCune, B. T.; Bailey, A. L.; Zhao, H.; VanBlargan, L. A.; Dai, Y. N.; Ma, M.; Adams, L. J.; Shrihari, S.; Danis, J. E.; Gralinski, L. E.; Hou, Y. J.; Schäfer, A.; Kim, A. S.; Keeler, S. P.; Weiskopf, D.; Baric, R. S.; Holtzman, M. J.; Fremont, D. H.; Curiel, D. T.; Diamond, M. S. A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2. Cell. 2020, 183:169-184.e13.

4. Amorij, J. P.; Saluja, V.; Petersen, A. H.; Hinrichs, W. L.; Huckriede, A.; Frijlink, H. W. Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice. Vaccine. 2007, 25, 8707-8717.

5. Wu, S.; Huang, J.; Zhang, Z.; Wu, J.; Zhang, J.; Hu, H.; Zhu, T.; Zhang, J.; Luo, L.; Fan, P.; Wang, B.; Chen, C.; Chen, Y.; Song, X.; Wang, Y.; Si, W.; Sun, T.; Wang, X.; Hou, L.; Chen, W. Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial. Lancet Infect Dis. 2021, 21, 1654-1664.

6. Jeyanathan, M.; Fritz, D. K.; Afkhami, S.; Aguirre, E.; Howie, K. J.; Zganiacz, A.; Dvorkin-Gheva, A.; Thompson, M. R.; Silver, R. F.; Cusack, R. P.; Lichty, B. D.; O’Byrne, P. M.; Kolb, M.; Medina, M. F. C.; Dolovich, M. B.; Satia, I.; Gauvreau, G. M.; Xing, Z.; Smaill, F. Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans. JCI Insight. 2022, 7, e155655.

7. Ye, T.; Jiao, Z.; Li, X.; He, Z.; Li, Y.; Yang, F.; Zhao, X.; Wang, Y.; Huang, W.; Qin, M.; Feng, Y.; Qiu, Y.; Yang, W.; Hu, L.; Hu, Y.; Zhai, Y.; Wang, E.; Yu, D.; Wang, S.; Yue, H.; Wang, Y.; Wang, H.; Zhu, L.; Ma, G.; Wei, W. Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization. Nature. 2023, 624, 630-638.

8. Lin, J.; Chen, L.; Yang, J.; Li, X.; Wang, J.; Zhu, Y.; Xu, X.; Cui, W. Injectable double positively charged hydrogel microspheres for targeting-penetration-phagocytosis. Small. 2022, 18, e2202156.

9. Le Tran, P.; Pham, T. T.; Lee, H. S.; Hahn, S.; Choi, J. U.; Kim, J. H.; Jiang, H. L.; Yook, S.; Jeong, J. H. Magnetic resonance imaging of pancreatic islets using tissue-adhesive particles containing iron oxide nanoparticles. J Control Release. 2023, 364, 37-45.

10. Wu, J.; Li, G.; Ye, T.; Lu, G.; Li, R.; Deng, L.; Wang, L.; Cai, M.; Cui, W. Stem cell-laden injectable hydrogel microspheres for cancellous bone regeneration. Chem Eng J. 2020, 393, 124715.

11. Yang, J.; Liang, J.; Zhu, Y.; Hu, M.; Deng, L.; Cui, W.; Xu, X. Fullerol-hydrogel microfluidic spheres for in situ redox regulation of stem cell fate and refractory bone healing. Bioact Mater. 2021, 6, 4801-4815.

12. Chen, Z.; Lv, Z.; Zhuang, Y.; Saiding, Q.; Yang, W.; Xiong, W.; Zhang, Z.; Chen, H.; Cui, W.; Zhang, Y. Mechanical signal-tailored hydrogel microspheres recruit and train stem cells for precise differentiation. Adv Mater. 2023, 35, e2300180.

13. Lei, Y.; Wang, Y.; Shen, J.; Cai, Z.; Zeng, Y.; Zhao, P.; Liao, J.; Lian, C.; Hu, N.; Luo, X.; Cui, W.; Huang, W. Stem cell-recruiting injectable microgels for repairing osteoarthritis. Adv Funct Mater. 2021, 31, 2105084.